Needle-Free Drug Delivery Devices Market Size, Share, Growth And Manufacturer Analysis And Forecasts To 2025

The Report Needle-Free Drug Delivery Devices Market Size, Share & Trends Analysis Report By Application, By Technology (Jet Injectors, Inhaler, Transdermal Patch, Novel Needle Free), and Segment Forecasts, 2018 – 2025

The global needle-free drug delivery device market size is poised to reach USD 16.27 billion by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 10.5% during the forecast period. Rising usage of injections in healthcare settings such as hospitals, clinics, and ambulatory surgical centers has led to spread of infectious diseases such as Hepatitis B, Hepatitis C, and AIDS, especially in developing countries. This acts as a key driver for the needle-less drug delivery devices industry. Furthermore, rising collaborations between market players is further likely to increase competitiveness of this market. For instance, PharmaJet and Mundipharma entered into a partnership in 2018 for distributing its needle free injectors over 120 markets globally.

Moreover, technological advancements in healthcare are expected to open new avenues for market players in applications such as cancer, AIDS, and Ataxic Cerebral Palsy. For instance, polycarbonate materials are being utilized in needle free injectors owing to their advantages such as design flexibility, toughness, light weight, and process ability. The most recent example of such technology is needle-free injection insulin delivery device manufactured by QS Medical Technology Co. (QS) in September 2018.

Access Research Report of Needle-Free Drug Delivery Devices Market @ www.grandviewresearch.com/industry-analysis/needle-free-drug-delivery-devices-market

Further key findings from the report suggest:

·       Novel needle-less devices accounted for a significant share of more than 25.00% in 2017 owing to their wide array of applications

·       Based on applications, the vaccine delivery segment is estimated to exhibit a lucrative growth rate over the forecast period due to its increasing usage for pediatric patients

·       North America held the dominant share in the global arena in 2017, due to favorable government insurance policies and increased investments in R&D by healthcare companies

·       For instance, In May 2018, U.S. Congress approved “right to try” bill where patients can try unproven medical treatments and devices in case of serious illness such as orphan diseases, including NETs

·       The Asia Pacific needle-free medication transportation devices industry is anticipated to witness significant growth during the same period due to rising healthcare expenditure and growing investments by many companies in the healthcare sector

·       Additionally, several countries in this region are implementing laws that cater to adoption of medical devices. For instance, the Korea-U.S. Free Trade Agreement (KORUS FTA) was implemented on March 15, 2012, in which most of the medical devices in Korea were made duty free

·       Some of the key companies present in the market are Antares Pharma; Injex Pharma Ag; Verdict Media Limited; Valeritas, Inc.; and 3M Company

·       Industry participants are involved in extensive research activities to develop novel needless drug delivery injectors for applications such as pain management, insulin drug delivery, and vaccines delivery.

Grand View Research has segmented the global needle-free medicine delivery device market on the basis of technology, application, and region:

Needle-Free Drug Delivery Device Technology Outlook (Revenue, USD Million, 2014 - 2025)

·         Jet injectors

·         Inhaler technology

·         Transdermal patch technology

·         Novel needle-free technologies

Needle-Free Drug Delivery Device Application Outlook (Revenue, USD Million, 2014 - 2025)

·         Others Vaccine delivery

·         Pain management

·         Insulin delivery for diabetes

·         Pediatric injections

·         Others

Needle-Free Drug Delivery Device Regional Outlook (Revenue, USD Million, 2014 - 2025)

·         North America

o    U.S.

o    Canada

·         Europe

o    U.K.

o    Germany

·         Asia Pacific

o    Japan

o    China

o    India

·         Latin America

o    Mexico

o    Brazil

·         Middle East & Africa

o    South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Craniomaxillofacial Devices Market Estimate, Industry Size, Share And Forecast Till 2026

The Report Craniomaxillofacial (CMF) Devices Market Analysis by Product (Cranial Flap Fixation, CMF Distraction, TMJ Replacement, Thoracic Fixation, Bone Graft Substitute), By Material, By Application, And Segment Forecasts, 2019 – 2026

The global craniomaxillofacial devices market size is expected to reach USD 3.88 billion by 2026, according to a new report by Grand View Research, Inc. It is projected to register a CAGR of 6.0% during the forecast period. Increasing incidence of facial fractures and demand for minimally invasive surgery for facial reconstruction are expected to drive the demand for Craniomaxillofacial (CMF) devices. Faster recovery, minimal incision to the body, and reduced complications associated with minimally invasive reconstructive surgeries are anticipated to contribute to the growth.

The introduction of technologically advanced procedures, such as robotic arm assisted CMF surgery and bioabsorbable implants for cranial fixation are expected to drive the demand for CMF devices. The advancement such as amplified use of virtual plating technology and development of cost effective thoracic fixation devices are attributed to the rising demand.

The market is competitive in nature as the manufacturers are involved in new product developments to increase their market penetration. Also, the companies are entering into collaborations and research alliance with other market players to increase their product portfolio. Various software and virtual three-dimensional (3D) technologies are adopted by companies to gain competitive edge. For instance, the introduction of technologically advanced 3D printing allows manufacturers to integrate materials from both facial and cranial reconstruction is expected to gain popularity in the forthcoming years.

Access Research Report of Craniomaxillofacial (CMF) Devices Market @ www.grandviewresearch.com/industry-analysis/craniomaxillofacial-devices-market

Further key findings from the study suggest: 

·       CMF plate and screw fixation led the product segment in 2018, owing to increasing number of CMF trauma and reconstruction procedures which are non-elective

·       Temporomandibular Joint (TMJ) replacement product segment expected to show lucrative growth over the forecast period

·       Metallic implants held the largest revenue share owing to the advantage associated with the device such as less corrosive nature and ability to provide rigid support to the fixators

·       CMF devices find the largest application in neurosurgery owing to, increasing CMF procedures in oncology and neurovascular surgeries

·       Asia Pacific is anticipated to register rapid growth in the forthcoming years owing to, the presence of high unmet needs coupled with increasing patient awareness and improving healthcare infrastructure

·       Three-dimensional printing allow integration of new material for reconstruction and cranial surgery, this attracts more manufacturers to make R&D investments for the development of advanced products

·       Key players operating in the craniomaxillofacial devices market include Johnson & Johnson (DePuy Synthes); Medtronic Inc.; and Zimmer-Biomet Inc. which make the entry for small organizations difficult

·       Moreover, stringent norms for product approval and post-approval performance monitoring regulated by authorities such as the U.S. Food and Drug Administration (FDA) and the American Academy of implant may act as a threat for new participants

Grand View Research has segmented the craniomaxillofacial devices market on the basis of the product, material, application, and region:

Craniomaxillofacial Devices Product Outlook (Revenue, USD Million, 2014 - 2026)

·         Cranial Flap Fixation

·         CMF Distraction

·         Temporomandibular Joint

·         Thoracic Fixation

·         Bone Graft Substitute

·         MF Plate and Screw Fixation

Craniomaxillofacial Devices Material Outlook (Revenue, USD Million, 2014 - 2026)

·         Metals

·         Bioabsorbable

·         Others

Craniomaxillofacial Devices Application Outlook (Revenue, USD Million, 2014 - 2026)

·         Neurosurgery and ENT

·         Orthognathic and Dental

·         Plastic Surgery

Craniomaxillofacial Devices Regional Outlook (Revenue, USD Million, 2014 - 2026)

·         North America

o    U.S.

o    Canada

·         Europe

o    U.K.

o    Germany

o    France

o    Italy

o    Spain

·         Asia Pacific

o    Japan

o    China

o    India

o    Australia

o    Singapore

o    Malaysia

·         Latin America

o    Mexico

o    Brazil

·         MEA

o    South Africa

o    Saudi Arabia

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Urolithiasis Management Devices Market Growth With Worldwide Industry Analysis To 2024

The Report Urolithiasis Management Devices Market Analysis By Treatment Type (Extracorporeal Shock Wave Lithotripsy (Eswl), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy, Other Treatments (Watchful Waiting, Parathyroid Gland Surgery)), By End Use (Hospitals & Clinics, Ambulatory Surgical Centers), And Segment Forecasts To 2024

The global urolithiasis management devices market was valued at USD 1.27 billion in 2015 and is expected to be valued at USD 1.93 billion by 2024. The alarming growth in the incidence rate of urinary stones, over the years, is responsible for the advancements in the treatment options. European Association of Urology states that it is one of the most common lifestyle disorders with a 10% prevalence rate and requires a systematic treatment approach.

Urolithiasis means formation of stones in the urinary system, mainly including the kidney, ureters, and the bladder. It is a major healthcare concern in the high end countries such as the U.S., Canada, and Germany with a recurrence rate of 50% in most of the cases. Urolithiasis can be managed with the help of lifestyle changes, controlled diet, or basic medication. However, various treatment approaches need to be adopted for the removal of large stones that cause severe pain. Depending upon the stone size, location in the body, and anatomical variations in the urogenital tract, invasive or noninvasive stone removal procedures are available. For instance, smaller stones can be tackled with external shock waves (extracorporeal shock wave lithotripsy), while larger stones can be removed through surgeries (intracorporeal lithotripsy or percutaneous nephrolithotomy).

Smaller stones generally do not require surgical interventions and can be cured with the help of medication and a healthy diet. However, larger stones necessitate different approaches for their elimination. Extracorporeal lithotripsy is one of the common treatments employed for stone elimination and held a majority market share in the year 2015. Intracorporeal lithotripsy treatments spot and reduce the stones to smaller pieces with the help of endoscopy. For the disintegration of stones, ultrasound or laser techniques are used to enable the passage of smaller fragments through the urinary system. Owing to the effective stone-free rate offered by intracorporeal lithotripsy, it is likely to be preferred as a treatment option during the forecast period.

Furthermore, percutaneous nephrolithotomy is a surgical approach deployed to eliminate larger stones where extracorporeal or intracorporeal lithotripsies prove to be ineffective and typically require a week’s hospitalization.

Ambulatory surgical centers are gaining popularity over traditional hospital and clinic settings due to the time and cost saving benefits. As a result, this end-use segment is expected to record a lucrative growth rate during the forecast period. Introduction of novel surgical technologies, such as endoscopy and micro accessories including guidewires, scalpels, and baskets, to effectively expel stones from the urinary system in a short time has enhanced the overall acceptability of minimally invasive surgeries.

Access Research Report of Urolithiasis Management Devices Market @ http://www.grandviewresearch.com/industry-analysis/urolithiasis-management-devices-market

Further Key Findings from the Study Suggest:

·       Urinary stones are highly prevalent worldwide with a 15% global target population and the recurrence rate of 50%. Men are more susceptible to developing renal stones than women.

·       Adoption and acceptance of intracorporeal lithotripsy contributed to more than 95% stone-free rate, which will render it the most preferred alternative over extracorporeal and subcutaneous treatments. On the other hand, ambulatory surgical centers will grow at a higher rate due to the associated benefits of lower cost and shorter perioperative time.

·       The upward trend in the adoption of sedentary lifestyle coupled with increased consumption of unhealthy food in the developed countries is responsible for the rising incidence of kidney stones. Ambulatory surgical service providers are expected to experience a surge in the treatment demand as a result of the unhealthy lifestyle changes, especially in the developed countries.

Grand View Research has segmented the urolithiasis management devices market by treatment type, end use, and region:

Treatment Type Outlook (Market revenue in USD Million, 2013 - 2024)

·         Extracorporeal Shock Wave Lithotripsy (ESWL)

·         Intracorporeal Lithotripsy

·         Percutaneous Nephrolithotomy

·         Other Treatments

End Use Outlook (Market Revenue in USD Million, 2013 - 2024)

·         Hospitals & Clinics

·         Ambulatory Surgical Centers

Regional Outlook (Market Revenue in USD Million, 2013 - 2024)

·         North America

·         Europe

·         Asia Pacific

·         Latin America

·         Middle East and Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com